cladribine has been researched along with Mast-Cell Leukemia in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (66.67) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Brand, T; Cross, NCP; Fabarius, A; Hofmann, WK; Horny, HP; Kreil, S; Lübke, J; Metzgeroth, G; Naumann, N; Reiter, A; Schwaab, J; Sotlar, K; Valent, P | 1 |
| Aichberger, KJ; Gleixner, KV; Kretschmer, A; Sperr, WR; Valent, P | 1 |
| Pardanani, A | 1 |
| Horny, HP; Noack, F; Notter, M; Penack, O; Sotlar, K; Thiel, E | 1 |
| Aichberger, KJ; Böhm, A; Derdak, S; Fabbro, D; Gleixner, KV; Gruze, A; Manley, PW; Mayerhofer, M; Pickl, WF; Samorapoompichit, P; Sillaber, C; Sonneck, K; Valent, P | 1 |
| Notter, M; Penack, O; Thiel, E | 1 |
1 review(s) available for cladribine and Mast-Cell Leukemia
| Article | Year |
|---|---|
Systemic mastocytosis in adults: 2012 Update on diagnosis, risk stratification, and management.
Topics: Adrenal Cortex Hormones; Adult; Bone Marrow Examination; Cell Lineage; Cladribine; Clinical Trials as Topic; Clone Cells; Disease Management; Disease Progression; Humans; Hydroxyurea; Immunophenotyping; Interferon-alpha; Leukemia, Mast-Cell; Mast Cells; Mastocytosis, Systemic; Mutation, Missense; Organ Specificity; Prognosis; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-kit; Risk Assessment; Staurosporine; Tryptases | 2012 |
5 other study(ies) available for cladribine and Mast-Cell Leukemia
| Article | Year |
|---|---|
Response and resistance to cladribine in patients with advanced systemic mastocytosis: a registry-based analysis.
Topics: Cladribine; Humans; Leukemia, Mast-Cell; Mastocytosis, Systemic; Prognosis; Registries | 2023 |
Treatment responses to cladribine and dasatinib in rapidly progressing aggressive mastocytosis.
Topics: Aged; Antineoplastic Agents; Cladribine; Dasatinib; Disease Progression; Drug Therapy, Combination; Fatal Outcome; Female; Humans; Leukemia, Mast-Cell; Mastocytosis, Systemic; Protein Kinase Inhibitors; Pyrimidines; Thiazoles; Treatment Failure; Tryptases | 2008 |
Cladribine therapy in a patient with an aleukemic subvariant of mast cell leukemia.
Topics: Aged; Antineoplastic Agents; Cladribine; Humans; Leukemia; Leukemia, Mast-Cell; Male; Radiography | 2005 |
PKC412 inhibits in vitro growth of neoplastic human mast cells expressing the D816V-mutated variant of KIT: comparison with AMN107, imatinib, and cladribine (2CdA) and evaluation of cooperative drug effects.
Topics: Anti-Bacterial Agents; Antigens, CD; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Benzamides; CD2 Antigens; Cell Proliferation; Cells, Cultured; Cladribine; Down-Regulation; Doxycycline; Drug Evaluation, Preclinical; Drug Interactions; Drug Synergism; Female; Humans; Imatinib Mesylate; Immunophenotyping; In Vitro Techniques; Leukemia, Mast-Cell; Middle Aged; Mutation; Phosphorylation; Piperazines; Platelet Membrane Glycoproteins; Protein Kinase C; Proto-Oncogene Proteins c-kit; Pyrimidines; Staurosporine; Tetraspanin 30 | 2006 |
Mast cell leukaemia.
Topics: Aged; Antineoplastic Agents; Cladribine; Humans; Leukemia, Mast-Cell; Male | 2005 |